Novel Drug Shows Hints of Promise for Progressive MS

(Medage today) – The Vidofluddimus calcium has missed its main target in a phase II exploratory study of progressive multiple sclerosis (MS) but has shown promising trends linked to disability, data from the caller tests have suggested. On…